Transapical Aortic Valve Implantation at 3 Years
Our objective was to analyze the results of transapical aortic valve implantation in high-risk patients with aortic stenosis at up to 3 years after the procedure.
You may also like
High Haematocrit in Cyanotic Congenital Heart Disease Affects how Fibrinogen Activity is Determined by Rotational Thromboelastometry
Supra-physiologic HCT causes abnormal ROTEM test results consistent with increased dilution of fibrinogen and coagulation factors in whole blood by red cells.
1 min read
Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic Review
Argatroban infusion rates and anticoagulation target ranges showed substantial variations. The rational for divergent dosing and monitoring approaches are discussed in this paper. Argatroban appears to be a potential alternative to UFH in patients requiring ECMO. To definitively establish its safety, efficacy and ideal dosing strategy, larger prospective studies on well-defined patient populations are warranted.
1 min read